日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial

Ifinatamab Deruxtecan治疗广泛期小细胞肺癌患者:II期IDeate-Lung01试验的主要分析

Rudin, Charles M; Johnson, Melissa L; Paz-Ares, Luis; Nishio, Makoto; Hann, Christine L; Girard, Nicolas; Rocha, Pedro; Hayashi, Hidetoshi; Sakai, Tetsuya; Kim, Yu Jung; Hu, Haichuan; Qian, Meng; Singh, Jasmeet; Godard, Juliette; Tang, Mei; Ahn, Myung-Ju

Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial

劳拉替尼治疗未接受过酪氨酸激酶抑制剂治疗的晚期 ROS1 阳性非小细胞肺癌:一项 II 期非随机临床试验

Ahn, Beung Chul; Kim, Yu Jung; Lee, Youngjoo; Suh, Koung Jin; Kim, Se Hyun; Kim, Dong-Wan; Kim, Tae Min; Lee, Ki Hyeong; Han, Ji-Youn

Basal Plane Activation of SnS(2) Thin-Film by Fluorine Doping for Selective Solar-Driven CO(2) Reduction With Enhanced Quantum Efficiency

通过氟掺杂活化SnS(2)薄膜的基面,实现选择性太阳能驱动的CO(2)还原,并提高量子效率

Mamo, Tadios Tesfaye; Qorbani, Mohammad; Hailemariam, Adane Gebresilassie; Raghunath, Putikam; Chu, Che-Men; Yuan, Wen-Hsin; Sabbah, Amr; Wang, Yen-Yu; Chang, Shuo-Yun; Lin, Ming-Chang; Woon, Wei-Yen; Lu, Yu-Jung; Wu, Heng-Liang; Wong, Ken-Tsung; Chen, Kuei-Hsien; Chen, Li-Chyong

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study

III期和IV期黑色素瘤抗PD-1免疫疗法耐药性:一项全球病例回顾研究

Gaughan, Elizabeth M; Kim, Miso; Mendez, Ignacio; Rao, Aparna D; Wei, Maria; So, Alexandra; Zhong, Xiaochen; Berking, Carola; Jiang, Ruixuan; Kim, Tae Min; Dalle, Stéphane; Robert, Caroline; Danson, Sarah; Alam, Salma; Charles, Julie; Davies, Tessa; Debus, Dirk; Dzienis, Marcin; Frazer, Ricky; Gebhardt, Christoffer; Geidel, Glenn; Hassel, Jessica C; Hansen, Inga; Heppt, Markus Vincent; Hildebrandt, Lina; Isaacs, James M; Suh, Koung Jin; Keam, Bhumsuk; Kim, Yu Jung; Lesimple, Thierry; Saiag, Philippe; Delibes, Alicia; Barnett, Rosemarie; Krepler, Clemens; Gandhi, Kavita; Qizilbash, Nawab; Shui, Irene M; Tan, Xiang-Lin; Sullivan, Ryan J

Pain and treatment outcomes after initiating methadone vs buprenorphine among medicare patients with opioid use disorder and comorbid chronic pain: A target trial emulation

针对患有阿片类药物使用障碍和合并慢性疼痛的医疗保险患者,美沙酮与丁丙诺啡治疗后的疼痛和治疗结果:一项目标试验模拟研究

Wei, Yu-Jung Jenny; Winterstein, Almut G; Fillingim, Roger B; Schmidt, Stephan; Schmidt, Siegfried

Enhancing Sky-Blue Perovskite Light-Emitting Diode Performance through Guanidinium-Based Dual-Functional Molecular Engineering

通过胍基双功能分子工程增强天蓝色钙钛矿发光二极管的性能

Teng, Yu-Hsiang; Li, Hou; Chen, Chiung-Han; Wang, Yen-Yu; Lin, Bi-Hsuan; Ni, I-Chih; Kuo, Chi-Ching; Lu, Yu-Jung; Chueh, Chu-Chen

UQCRC1 deficiency impairs mitophagy via PINK1-dependent mechanisms in Parkinson's disease.

UQCRC1 缺陷通过 PINK1 依赖性机制损害帕金森病中的线粒体自噬。

Li Jeng-Lin, Huang Shu-Yi, Huang Po-Yu, Fu Ssu-Ju, Tsao Yu-Jung, Chang Wenying, Hong Cheng-Li, Hung Yu-Chien, Liu Pei-Han, Lai Liang-Chuan, Lin Chin-Hsien, Chiang Wei-Chung, Chan Chih-Chiang

ATP7B-maintained copper stores in myeloid progenitors are required for functional maturation of neutrophils.

髓系祖细胞中由 ATP7B 维持的铜储存是中性粒细胞功能成熟所必需的。

Dev Som, Wang Yu, Jung Moonjung, Ma Yingze, Mani Sepehr, Kabin Ekaterina, Yuda Ridzky, Dong Yixuan, Ralle Martina, Hamilton James P, Lutsenko Svetlana

Epigenetic inhibition of class I histone deacetylases by MS-275 attenuates diabetic skeletal muscle atrophy via Akt/ARK5-FoxO and myostatin-Smad signaling.

MS-275 通过 Akt/ARK5-FoxO 和肌肉生长抑制素-Smad 信号通路抑制 I 类组蛋白去乙酰化酶的表观遗传作用,从而减轻糖尿病骨骼肌萎缩。

Son Youngho, Byeon Hye-Eun, Choi Sung-E, Kim Youngha, Heo Yu Jung, Kwon Soon Beom, Choi Jaemyung, Han Seung Jin, Jeon Jayoung, Kim Hae Jin, Lee Nami, Lee Kwan-Woo

miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells.

miR-100-5p 通过调节奥沙利铂耐药结直肠癌细胞中的 CTDSPL/pRB/E2F1 信号通路增强细胞周期介导的化疗耐药性。

Chen Yen-Pin, Baskaran Rathinasamy, Devi Hema Sri, Singh Chaouhan Hitesh, Lin Yu-Jung, Shibu Marthandam Asokan, Kuo Wei-Wen, Liao Shih-Chieh, Chen Ming-Cheng, Wang Tso-Fu, Li Chi-Cheng, Ho Tsung-Jung, Shih Tzu-Ching, Lin Shinn-Zong, Huang Chih-Yang